ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Recs

1
Player Avatar yesand (31.96) Submitted: 7/29/2011 2:48:48 PM : Outperform Start Price: $18.07 VPHM Score: +9.71

Good pharma in pipeline

Featured Broker Partners


Advertisement